AICAR's Effects on Childhood Leukemia Cells
Author Information
Author(s): Sengupta Tapas K, Leclerc Gilles M, Hsieh-Kinser Ting, Leclerc Guy J, Singh Inderjit, Barredo Julio C
Primary Institution: University of Miami Miller School of Medicine
Hypothesis
Can AICAR activate AMPK to inhibit growth and induce apoptosis in childhood acute lymphoblastic leukemia (ALL) cells?
Conclusion
AICAR effectively inhibits growth and induces apoptosis in ALL cells through AMPK activation.
Supporting Evidence
- AICAR treatment inhibited cell proliferation in ALL cells.
- AICAR induced cell cycle arrest in G1-phase.
- AICAR treatment led to increased expression of p27 and p53.
- AICAR-mediated apoptosis was confirmed by cytochrome C release.
- Combination treatment with AICAR and rapamycin enhanced anti-proliferative effects.
Takeaway
AICAR is a special medicine that helps stop cancer cells from growing and can make them die, which is good for treating kids with leukemia.
Methodology
The study evaluated the effects of AICAR on cell growth, cell cycle regulators, and apoptosis in various childhood ALL cell lines.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Participant Demographics
Childhood acute lymphoblastic leukemia (ALL) cell lines were used.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website